These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8133 related articles for article (PubMed ID: 10652566)

  • 21. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
    Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
    Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
    Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.
    Ju DW; Cao X; Acres B
    Cancer Gene Ther; 1997; 4(2):139-44. PubMed ID: 9080123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.
    Miguel A; Herrero MJ; Sendra L; Botella R; Algás R; Sánchez M; Aliño SF
    Cancer Gene Ther; 2013 Oct; 20(10):576-81. PubMed ID: 23969885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy with tumor vaccine increases the survival of hepatoma-bearing mice.
    Chao Y; Shih YL; Cheng HJ; Wei SJ; Chi KH; Yeh SH; Lee SD; Yang WK
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):682-9. PubMed ID: 10533297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines.
    Hodge JW; Schlom J
    Cancer Res; 1999 Oct; 59(20):5106-11. PubMed ID: 10537283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
    Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy.
    Chen Y; Chang KJ; Hwang LH; Chen CN; Tseng SH
    Int J Colorectal Dis; 2002 Nov; 17(6):388-95. PubMed ID: 12355214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigens and cytokine genes in antitumor vaccines: the importance of the temporal delivery sequence in antitumor signals.
    Herrero MJ; Botella R; Dasí F; Algás R; Sánchez M; Aliño SF
    Ann N Y Acad Sci; 2006 Dec; 1091():412-24. PubMed ID: 17341632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M
    Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
    Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N
    Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
    Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
    von Mehren M; Arlen P; Gulley J; Rogatko A; Cooper HS; Meropol NJ; Alpaugh RK; Davey M; McLaughlin S; Beard MT; Tsang KY; Schlom J; Weiner LM
    Clin Cancer Res; 2001 May; 7(5):1181-91. PubMed ID: 11350882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.
    Qin H; Valentino J; Manna S; Tripathi PK; Bhattacharya-Chatterjee M; Foon KA; O'Malley BW; Chatterjee SK
    Mol Ther; 2001 Dec; 4(6):551-8. PubMed ID: 11735339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.
    Chen SA; Tsai MH; Wu FT; Hsiang A; Chen YL; Lei HY; Tzai TS; Leung HW; Jin YT; Hsieh CL; Hwang LH; Lai MD
    Clin Cancer Res; 2000 Nov; 6(11):4381-8. PubMed ID: 11106257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine.
    Prell RA; Li B; Lin JM; VanRoey M; Jooss K
    Cancer Res; 2005 Mar; 65(6):2449-56. PubMed ID: 15781661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 407.